Biocompatibility of heparin-coated circuits used in cardiopulmonary bypass.
暂无分享,去创建一个
P. Venge | M. Pekna | M. Fagerhol | S. Thelin | J. Borowiec
[1] I. Olsson,et al. Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukaemia. , 2009, Scandinavian Journal of Haematology.
[2] S. Thelin,et al. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. , 2008, Artificial organs.
[3] J. van der Linden,et al. Heparin coating reduces blood cell adhesion to arterial filters during coronary bypass: a clinical study. , 1993, The Annals of thoracic surgery.
[4] W. van Oeveren,et al. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[5] E. Fosse,et al. Calprotectin and complement activation during major operations with or without cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[6] B. Nilsson,et al. Modification of the Complement Binding Properties of Polystyrene: Effects of End‐Point Heparin Attachment , 1993, Scandinavian Journal of Immunology.
[7] S Westaby,et al. Inflammatory response to cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[8] A. Røseth,et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. , 1992, Scandinavian journal of gastroenterology.
[9] P. Venge,et al. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. , 1992, The Journal of thoracic and cardiovascular surgery.
[10] E. Fosse,et al. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. , 1992, The Journal of thoracic and cardiovascular surgery.
[11] B. Nilsson,et al. Generation of iC3 at the Interface between Blood and Gas , 1992, Scandinavian journal of immunology.
[12] R. Davey,et al. Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass. The effect of blood transfusion. , 1991, The Journal of thoracic and cardiovascular surgery.
[13] S. Hagl,et al. The influence of extracorporeal circulation and hemoseparation on red cell deformability and membrane proteins in coronary artery disease. , 1990, The Journal of thoracic and cardiovascular surgery.
[14] M. Fagerhol,et al. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. , 1989, The Journal of rheumatology.
[15] R. Larsson,et al. The Search for Thromboresistance Using Immobilized Heparin , 1987, Annals of the New York Academy of Sciences.
[16] S. Frøland,et al. Quantification of the Terminal Complement Complex in Human Plasma by an Enzyme‐Linked Immunosorbent Assay Based on Monoclonal Antibodies against a Neoantigen of the Complex , 1985, Scandinavian journal of immunology.
[17] S Westaby,et al. Complement and the damaging effects of cardiopulmonary bypass. , 1983, Thorax.
[18] D. Stroncek,et al. Complement activation and neutropenia occurring during cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.
[19] J. Heremans,et al. Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.
[20] B. Nilsson,et al. Complement activation by polymethyl methacrylate minimized by end-point heparin attachment. , 1993, Biomaterials.
[21] H. Hansson,et al. Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose. , 1992, Scandinavian journal of thoracic and cardiovascular surgery.
[22] A. Semb,et al. Cardiac surgery and distribution of the leukocyte L1 protein-calprotectin. , 1991, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[23] M. Turina,et al. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization. , 1990, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[24] M. Kazatchkine,et al. Biocompatibility of extracorporeal circuits in heart surgery. , 1990, Transfusion science.
[25] R. Colman,et al. Platelet and neutrophil activation in cardiopulmonary bypass. , 1990, The Annals of thoracic surgery.
[26] I. Brandslund,et al. Neutrophil lysosomal enzyme release and complement activation during cardiopulmonary bypass. , 1987, Scandinavian journal of thoracic and cardiovascular surgery.
[27] J. Bakken,et al. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. , 1984, Scandinavian journal of clinical and laboratory investigation.
[28] R. Larsson,et al. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. , 1983, Biomaterials, medical devices, and artificial organs.